COLLEGIUM PHARMACEUTICAL, INC (COLL) Amortization of Intangible Assets USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2016 to 2024.
  • Collegium Pharmaceutical, Inc Amortization of Intangible Assets for the quarter ending March 31, 2024 was $34.5 M, a 7.87% decline year-over-year.
  • Collegium Pharmaceutical, Inc annual Amortization of Intangible Assets for 2021 was $67.2 M, a 10.7% increase from 2020.
  • Collegium Pharmaceutical, Inc annual Amortization of Intangible Assets for 2020 was $60.7 M, a 311% increase from 2019.
  • Collegium Pharmaceutical, Inc annual Amortization of Intangible Assets for 2019 was $14.8 M, a 86.6% decline from 2018.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $34.5 M -$2.95 M -7.87% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 $36.3 M -$1.24 M -3.29% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $37.5 M -$38 K -0.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $37.5 M +$18.5 M +98% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $111 M $37.6 M +$20.8 M +124% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $90 M $37.5 M +$20.7 M +123% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $69.3 M $18.9 M +$2.13 M +12.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $67.2 M $16.8 M $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-24
Q3 2021 $67.2 M $16.8 M +$1 K +0.01% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $67.2 M $16.8 M $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $67.2 M $16.8 M +$6.5 M +63.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $60.7 M $16.8 M +$13.1 M +355% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $47.6 M $16.8 M +$13.1 M +355% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 $34.5 M $16.8 M +$13.1 M +355% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 $21.4 M $10.3 M +$6.61 M +179% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 $14.8 M $3.69 M -$11.8 M -76.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $26.6 M $3.69 M -$28.7 M -88.6% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 $55.3 M $3.69 M -$28.7 M -88.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 $84 M $3.69 M -$25.8 M -87.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 $110 M $15.5 M +$15.5 M +46852% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $94.4 M $32.4 M +$32.4 M +67415% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $62 M $32.4 M +$32.4 M +68851% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $29.7 M $29.5 M +$29.4 M +22612% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $258 K $33 K Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $48 K -$179 K -78.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $47 K +$47 K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $130 K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q3 2016 $227 K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.